Parenteral Nutrition Products Market

Global Parenteral Nutrition Products Market Size, Share & Trends Analysis Report, By Type (Carbohydrates, Parenteral Lipid Emulsions, Single Dose Amino Acid Solutions, Trace Elements, Electrolytes and Minerals, and Vitamins), By Application (Premature Infants, Neonates and Children, Geriatrics, and Chronic Disease Patients), Forecast (2022-2028)
    Update Available - Forecast 2024-2030   

Published: Jul 2023 | Report Code: | Category : Pharmaceuticals | Delivery Format: /

The global parenteral nutrition products market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Parenteral nutrition is delivered as a specialized form of food through the veins for the treatment to correct or prevent malnutrition. The major factor for the growth of the market is the increasing prevalence of malnutrition, particularly in developing and under-developed countries across the globe. As per the Our World in Data, 8.8% of the population is undernourished globally. Additionally, an estimated 663 million people are undernourished with 22% of children younger than five years of age being stunted. These children are significantly shorter than the average for their age due to poor nutrition or repeated infection. Furthermore, 9% of the population which is around 697 million people are severely food insecure while one-in-four people around 1.9 billion are moderately or severely food insecure across the globe. Hence, the increasing prevalence of malnutrition or undernutrition is driving the demand for global parenteral nutrition products which is driving the market growth. 

Furthermore, the COVID-19 pandemic has provided a major boost to the market growth in the past two years. The growing preference for parenteral nutrition products over enteral nutrition in patients with COVID-19 is also expected to boost these products' demand, thereby leading the market growth. According to the ASPEN20 Virtual Conference, providing appropriate nutrition to adults with COVID-19 is a priority for enhancing recovery. All these factors are likely to spur the global parenteral nutrition products market growth.

Market Coverage

  • The market number available for – 2021-2028
  • Base year- 2021
  • Forecast period- 2022-2028

Segment Covered- 

  • By Type
  • By Application

Regions covered-

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Competitive Landscape:  Pfizer Inc., Baxter International Inc., and B. Braun Melsungen AG, among others.

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominate the market in the base year?
  • Which segment and region will project the fastest growth in the market?
  • How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

  • Who is the leader in the market?
  • How are players addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Parenteral Nutrition Products Market Report by Segment

By Type

  • Carbohydrates
  • Parenteral Lipid Emulsions
  • Single Dose Amino Acid Solutions
  • Trace Elements
  • Electrolytes
  • Minerals and Vitamins

By Application

  • Premature Infants
  • Neonates and Children
  • Geriatrics
  • Chronic Disease Patients

Global Parenteral Nutrition Products Market Report by Region

North America       

  • US
  • Canada

Europe

  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe

Asia-Pacific    

  • China
  • Japan
  • India
  • Rest of Asia-Pacific

Rest of the World

  • Latin America
  • Middle East and Africa